Cargando…

Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis

BACKGROUND: Systemic sclerosis is a connective tissue disease characterized by vasculopathy and progressive fibrosis, leading to multiorgan dysfunction. Given the complex and not fully elucidated pathogenesis, biomarkers of rapid disease progression and therapeutic response are lacking. Copeptin, wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maciejewska, Magdalena, Stec, Albert, Zaremba, Michał, Maciejewski, Cezary, Rudnicka, Lidia, Sikora, Mariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226486/ https://www.ncbi.nlm.nih.gov/pubmed/37255624 http://dx.doi.org/10.2147/CCID.S409490

Ejemplares similares

Hypoxia-Inducible Factor-1α (HIF-1α) as a Biomarker for Changes in Microcirculation in Individuals with Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2023)

The Clinical Significance of Serum Biomarkers of the Intestinal Barrier in Systemic Sclerosis: A Cross-Sectional Study
por: Stec, Albert, et al.
Publicado: (2023)

Raynaud’s Phenomenon with Focus on Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2022)

The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
por: Stec, Albert, et al.
Publicado: (2023)

Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2019)

Bacterial Metabolites: A Link between Gut Microbiota and Dermatological Diseases
por: Stec, Albert, et al.
Publicado: (2023)

The Clinical Significance of Salusins in Systemic Sclerosis—A Cross-Sectional Study
por: Nowaczyk, Joanna, et al.
Publicado: (2023)

Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
por: Stochmal, Anna, et al.
Publicado: (2019)

Future Treatment Options in Systemic Sclerosis—Potential Targets and Ongoing Clinical Trials
por: Bohdziewicz, Anna, et al.
Publicado: (2022)

Circulating peroxisome proliferator-activated receptor γ is elevated in systemic sclerosis
por: Żółkiewicz, Jakub, et al.
Publicado: (2019)

Clinical Implications of Intestinal Barrier Damage in Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2021)

Gut Microbiome in Psoriasis: An Updated Review
por: Sikora, Mariusz, et al.
Publicado: (2020)

Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study
por: Sikora, Mariusz, et al.
Publicado: (2021)

Impaired skeletal muscle microcirculation in systemic sclerosis
por: Partovi, Sasan, et al.
Publicado: (2012)

Copeptin as a Serum Biomarker of Febrile Seizures
por: Stöcklin, Benjamin, et al.
Publicado: (2015)

Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review
por: Nowaczyk, Joanna, et al.
Publicado: (2020)

Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2023)

Copeptin under glucagon stimulation
por: Lewandowski, Krzysztof C., et al.
Publicado: (2015)

Adiponectin as a novel biomarker of disease severity in alopecia areata
por: Stochmal, Anna, et al.
Publicado: (2021)

Copeptin in hyponatremia: is there a role for this biomarker in the diagnostic workup?
por: Baldrighi, Marco, et al.
Publicado: (2018)

Copeptin: a neuroendocrine biomarker of COVID-19 severity
por: Hammad, Reham, et al.
Publicado: (2022)

Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases
por: Mu, Danni, et al.
Publicado: (2022)

Lipocalin-2 and insulin as new biomarkers of alopecia areata
por: Waśkiel-Burnat, Anna, et al.
Publicado: (2022)

Eye Sign is an Alternative for Evaluation of the Microcirculation in Patients with Systemic Sclerosis
por: Yu, Shujiao, et al.
Publicado: (2022)

Copeptin as a marker of an altered CRH axis in pituitary disease
por: Lewandowski, Krzysztof C., et al.
Publicado: (2017)

The role of adipokines in systemic sclerosis: a missing link?
por: Żółkiewicz, Jakub, et al.
Publicado: (2019)

Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia
por: Seligman, Renato, et al.
Publicado: (2008)

Is copeptin a reliable biomarker of primary monosymptomatic nocturnal enuresis?
por: Szymanik-Grzelak, Hanna, et al.
Publicado: (2019)

Copeptin as a Biomarker of Atherosclerosis in Type 1 Diabetic Patients
por: El Dayem, Soha M. Abd, et al.
Publicado: (2020)

Copeptin in anorexia nervosa
por: Goetze, Jens P., et al.
Publicado: (2020)

Dermatoscopy of Cutaneous Lichen Planus – Attempt to Translate Metaphoric Terminology Into Descriptive Terminology
por: Szykut-Badaczewska, Agata, et al.
Publicado: (2023)

Retracted: Eye Sign is an Alternative for Evaluation of the Microcirculation in Patients with Systemic Sclerosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients
por: Waszczykowska, Arleta, et al.
Publicado: (2014)

Effects of treatment with rituximab on microcirculation in patients with long-term systemic sclerosis
por: Vilela, Verônica Silva, et al.
Publicado: (2018)

Sinoatrial conduction abnormalities – an underestimated cardiac complication in women with systemic sclerosis
por: Kramarz, Elżbieta, et al.
Publicado: (2021)

Copeptin: a novel prognostic biomarker in trauma: a review article
por: Sarkarinejad, Artin, et al.
Publicado: (2023)

Copeptin analysis in endocrine disorders
por: Moodley, Nareshni
Publicado: (2023)

Copeptin Implementation on Stroke Prognosis
por: Karatzetzou, Stella, et al.
Publicado: (2023)

Copeptin in aneurysmal subarachnoid hemorrhage
por: Tamargo, Rafael J
Publicado: (2012)

Arginine Vasopressin and Copeptin in Perinatology
por: Evers, Katrina Suzanne, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hnl0ees91th7euicutkp9uqlhu